Exercise benefit to lifespan may be due to stem cell increase

Diagnosis of blood cancer after a breast cancer diagnosis

Histone deacetylases targeted as new strategy against graft versus host disease

The BTK inhibitor ibrutinib (PCI-32765) in combination with rituximab

Neratinib shows beneficial effects in the treatment of HER2 mutated breast cancer

Adjuvant chemotherapy for locally recurrent breast cancer

Breast cancer hypo-fractionated radiotherapy offers long-term tumour control

Effectiveness of sentinel lymph node surgery after chemotherapy in node-positive breast cancer

Extending adjuvant trastuzumab treatment time provided no additional benefit

Breast cancer genome sequencing identified HER2 mutations as targets for drug treatment

Phase III trial did not show superiority of eribulin compared with capecitabine in metastatic breast cancer

Effect of hypoxia on cancer progression and adaptive response